643 related articles for article (PubMed ID: 16965416)
1. Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis.
Körver JE; van Duijnhoven MW; Pasch MC; van Erp PE; van de Kerkhof PC
Br J Dermatol; 2006 Oct; 155(4):688-94. PubMed ID: 16965416
[TBL] [Abstract][Full Text] [Related]
2. The combination of the Zenon labeling technique and microscopic image analysis to study cell populations in normal and psoriatic epidermis.
van Duijnhoven MW; van de Kerkhof PC; Pasch MC; Muys L; van Erp PE
J Cutan Pathol; 2005 Mar; 32(3):212-9. PubMed ID: 15701083
[TBL] [Abstract][Full Text] [Related]
3. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late.
Vissers WH; Arndtz CH; Muys L; Van Erp PE; de Jong EM; van de Kerkhof PC
Br J Dermatol; 2004 May; 150(5):852-9. PubMed ID: 15149496
[TBL] [Abstract][Full Text] [Related]
4. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
Bovenschen HJ; Seyger MM; Van de Kerkhof PC
Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
[TBL] [Abstract][Full Text] [Related]
5. Distribution of dipeptidyl-peptidase IV on keratinocytes in the margin zone of a psoriatic lesion: a comparison with hyperproliferation and aberrant differentiation markers.
van Lingen RG; Poll MK; Seyger MM; de Jong EM; van de Kerkhof PC; van Erp PE
Arch Dermatol Res; 2008 Nov; 300(10):561-7. PubMed ID: 18496701
[TBL] [Abstract][Full Text] [Related]
6. Changes in keratin 6 and keratin 10 (co-)expression in lesional and symptomless skin of spreading psoriasis.
Mommers JM; van Rossum MM; van Erp PE; van De Kerkhof PC
Dermatology; 2000; 201(1):15-20. PubMed ID: 10971053
[TBL] [Abstract][Full Text] [Related]
7. Recruitment of cycling epidermal cells and expression of filaggrin, involucrin and tenascin in the margin of the active psoriatic plaque, in the uninvolved skin of psoriatic patients and in the normal healthy skin.
Gerritsen MJ; Elbers ME; de Jong EM; van de Kerkhof PC
J Dermatol Sci; 1997 Mar; 14(3):179-88. PubMed ID: 9138475
[TBL] [Abstract][Full Text] [Related]
8. Novel functional multiparameter flow cytometric assay to characterize proliferation in skin.
Mommers JM; Goossen JW; van De Kerkhof PC; van Erp PE
Cytometry; 2000 Feb; 42(1):43-9. PubMed ID: 10679742
[TBL] [Abstract][Full Text] [Related]
9. Novel quantitative immunofluorescent technique reveals improvements in epidermal cell populations after mild treatment of psoriasis.
van Duijnhoven MW; Hagenberg R; Pasch MC; van Erp PE; van de Kerkhof PC
Acta Derm Venereol; 2005; 85(4):311-7. PubMed ID: 16191851
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, randomized quantitative comparison of calcitriol ointment and calcipotriol ointment on epidermal cell populations, proliferation and differentiation.
Körver JE; Vissers WH; van Rens DW; Pasch MC; van Erp PE; Boezeman JB; van De Kerkhof PC
Br J Dermatol; 2007 Jan; 156(1):130-7. PubMed ID: 17199579
[TBL] [Abstract][Full Text] [Related]
11. Transition from symptomless to lesional psoriatic skin.
Van de Kerkhof PC; Gerritsen MJ; de Jong EM
Clin Exp Dermatol; 1996 Sep; 21(5):325-9. PubMed ID: 9136148
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments.
van Erp PE; Rijzewijk JJ; Boezeman JB; Leenders J; de Mare S; Schalkwijk J; van de Kerkhof PC; Ramaekers FC; Bauer FW
Am J Pathol; 1989 Nov; 135(5):865-70. PubMed ID: 2479273
[TBL] [Abstract][Full Text] [Related]
13. Effect of calcipotriol on epidermal cell populations in alefacept-treated psoriatic lesions.
van Duijnhoven MW; Körver JE; Vissers WH; van Vlijmen-Willems IM; Pasch MC; van Erp PE; Van de Kerkhof PC
J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):27-33. PubMed ID: 16405604
[TBL] [Abstract][Full Text] [Related]
14. Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin.
Smit JV; de Jong EM; van Hooijdonk CA; Otero ME; Boezeman JB; van de Kerkhof PC
J Am Acad Dermatol; 2004 Aug; 51(2):257-64. PubMed ID: 15280845
[TBL] [Abstract][Full Text] [Related]
15. Nature of cell kinetics in psoriatic epidermis.
Doger FK; Dikicioglu E; Ergin F; Unal E; Sendur N; Uslu M
J Cutan Pathol; 2007 Mar; 34(3):257-63. PubMed ID: 17302610
[TBL] [Abstract][Full Text] [Related]
16. K16 expression in uninvolved psoriatic skin: a possible marker of pre-clinical psoriasis.
Bhawan J; Bansal C; Whren K; Schwertschlag U;
J Cutan Pathol; 2004 Aug; 31(7):471-6. PubMed ID: 15239676
[TBL] [Abstract][Full Text] [Related]
17. Monitoring hyperproliferative disorders in human skin: flow cytometry of changing cytokeratin expression.
Franssen ME; Boezeman JB; Van De Kerkhof PC; Van Erp PE
Cytometry B Clin Cytom; 2004 Jan; 57(1):32-9. PubMed ID: 14696061
[TBL] [Abstract][Full Text] [Related]
18. The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis.
Castelijns FA; Gerritsen MJ; van Vlijmen-Willems IM; van Erp PE; van de Kerkhof PC
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):901-9. PubMed ID: 10365920
[TBL] [Abstract][Full Text] [Related]
19. IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production.
Wei L; Debets R; Hegmans JJ; Benner R; Prens EP
J Pathol; 1999 Feb; 187(3):358-64. PubMed ID: 10398092
[TBL] [Abstract][Full Text] [Related]
20. Markers for proliferation and keratinization in the margin of the active psoriatic lesion.
de Mare S; de Jong E; Van Erp PE; Van de Kerkhof PC
Br J Dermatol; 1990 Apr; 122(4):469-75. PubMed ID: 1692474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
